The evolving role of DNA demethylating agents in the treatment of sickle cell disease and thalassemia

Semin Hematol. 2004 Oct;41(4 Suppl 6):1-3. doi: 10.1053/j.seminhematol.2004.08.001.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Anemia, Sickle Cell / drug therapy*
  • DNA Methylation / drug effects*
  • Fetal Hemoglobin / analysis
  • Fetal Hemoglobin / drug effects
  • Fetal Hemoglobin / genetics
  • Humans
  • Thalassemia / drug therapy*

Substances

  • Fetal Hemoglobin